• Home
  • Company
    • About
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Investors
  • Science
    • Approach
    • PAR Therapeutics
  • Pipeline
  • News
    • Press Releases
    • Posters & Publications
  • Amyloidosis
  • Careers
  • Contact
Attralus Inc. logo
  • Home
  • Company
    • About
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Investors
  • Science
    • Approach
    • PAR Therapeutics
  • Pipeline
  • News
    • Press Releases
    • Posters & Publications
  • Amyloidosis
  • Careers
  • Contact
Posters & Publications

Automatic quantification of AL and ATTR amyloidosis disease burden using 124I-evuzamitide, a novel radiotracer

May 28, 2024

Click Here to View Poster
Back to All News
COMPANY
About
Management Team
Board of Directors
Scientific Advisory Board
Investors
SCIENCE

Approach
Pan-Amyloid Removal (PAR)
Pan-Amyloid Diagnostic

PIPELINE

 

NEWS

Press Releases
Posters & Publications
In the News

HOME
AMYLOIDOSIS
CAREERS
CONTACT
  • Privacy Policy
  • Terms of Service
  • Follow
  • Follow

Attralus, Inc.
‍365 Fifth Ave, Ste 208
Naples, FL 34102

©2024 Attralus, Inc.  All Rights Reserved.